Page last updated: 2024-09-03

sk&f 86466 and Chronic Disease

sk&f 86466 has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Denson, DD; Haygood, RM; Hord, AH; Stowe, B	1

Other Studies

1 other study(ies) available for sk&f 86466 and Chronic Disease

Article	Year
alpha-1 and alpha-2 Adrenergic antagonists relieve thermal hyperalgesia in experimental mononeuropathy from chronic constriction injury. Anesthesia and analgesia, 2001, Volume: 92, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Benzazepines; Chronic Disease; Constriction, Pathologic; Dose-Response Relationship, Drug; Hyperalgesia; Male; Pain Measurement; Phentolamine; Prazosin; Rats; Rats, Sprague-Dawley	2001

Article

Year

alpha-1 and alpha-2 Adrenergic antagonists relieve thermal hyperalgesia in experimental mononeuropathy from chronic constriction injury.

Anesthesia and analgesia, 2001, Volume: 92, Issue:6

Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Benzazepines; Chronic Disease; Constriction, Pathologic; Dose-Response Relationship, Drug; Hyperalgesia; Male; Pain Measurement; Phentolamine; Prazosin; Rats; Rats, Sprague-Dawley

2001